TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
DXCM

DexCom Inc

Healthcare · Medical Devices

89.40$ +1.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement DXCM
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
32.0% 30.7% 34.0% 31.5% 35.6% 36.9% 33.6% 31.4% 35.3% 36.8% 39.5% 39.9%
68.0% 69.3% 66.0% 68.5% 64.4% 63.1% 66.4% 68.6% 64.7% 63.2% 60.5% 60.1%
26.8% 34.2% 27.2% 25.8% 40.5% 18.5% 18.7% 24.7% 16.6% 14.0% 13.7% 12.9%
49.5% 49.3% 47.8% 45.6% 39.6% 32.7% 28.2% 27.9% 29.8% 27.7% 27.1% 27.7%
76.3% 83.5% 77.1% 74.4% 82.4% 53.5% 50.9% 57.8% 51.3% 46.7% 45.6% 40.5%
-8.3% -14.2% -11.1% -5.9% -18.1% 9.6% 15.5% 10.9% 13.4% 16.5% 14.9% 19.6%
0.3% 0.1% 0.1% 1.8% 2.2% 4.1% 4.4% 0.8% 0.6% 0.6% 0.5% 0.4%
-8.6% -14.3% -11.3% -6.8% -12.3% 7.1% 11.7% 10.5% 13.4% 19.6% 17.6% 23.3%
0.0% 0.0% 0.1% 0.2% 0.1% 0.2% -13.9% 1.6% 1.7% 4.7% 3.3% 5.4%
-8.6% -14.3% -11.4% -7.0% -12.3% 6.8% 25.6% 8.9% 11.7% 14.9% 14.3% 17.9%
-5.1% -11.5% -8.6% -2.7% -7.2% 14.4% 19.6% 15.4% 19.4% 25.3% 23.4% 29.1%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?